Investment ThemesDetailed Quotes
Weight Loss Drugs
Watchlist
GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
- 1667.993
- -36.879-2.16%
Close Nov 12 16:00 ET
1694.859High1662.222Low
1692.029Open1704.871Pre Close95.85MVolume1Rise60.88P/E (Static)7.42BTurnover--Flatline0.91%Turnover Ratio1.57TMarket Cap6Fall1.44TFloat Cap
Constituent Stocks: 7Top Rising: ALT+29.12%
do
u
diva gal dive
Pfizer (PFE) is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value, looks to divest non-core assets, according to three people familiar with the matter.
The unit, now called Pfizer Hospital, was formed after Pfizer bought Hospira for about $17 billion in 2015. The pharma giant has hired Goldman Sachs to gauge initial interest from potential buyers, which include private equity firms and other phar...
Looking back at my recent investment decisions, I realized there were some interesting psychological factors at play. I had predicted that Tesla would likely surge following Trump’s successful election, yet I chose to invest in Pfizer instead—a stock that seemed “on the ground” with little attention from the market. In my mind, where the hype fades, potential often emerges. I believed th...
No comment yet